Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.38 +0.03 (+2.58%)
As of: Sep 30, 2026 · 3:59 PM EDT

Alx Oncology Holdings (ALXO) Common Equity (2019 - 2026)

Updated

Alx Oncology Holdings (ALXO) recorded Common Equity of $136.19 million in Q2 2026, up 111.4% from $64.42 million a year earlier but down 10.0% from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Common Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Alx Oncology Holdings reported Common Equity of $25.98 million, down 77.1% from FY2024.

  • Annual Common Equity has declined for five straight years, with a five-year compound annual growth rate of -42.9% (FY2020 to FY2025).
  • Across earlier years, Common Equity came in at $113.62 million in FY2024 (-40.1%), $189.71 million in FY2023 (-28.0%), $263.46 million in FY2022 (-27.4%) and $363.05 million in FY2021 (-15.5%).
  • Quarterly Common Equity has ranged from $25.98 million in Q4 2025 to $385.17 million in Q3 2021 over the past five years.
  • On a year-over-year basis, Common Equity rose in two of the last eight quarters, with an average decline of 15.8%.
  • Peak year-over-year performance for Common Equity in the last five years was growth of 111.4% in Q2 2026, against a decline of 77.1% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $151.35 million (Q1 2026), $25.98 million (Q4 2025) and $44.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 84.97 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -5.94 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 50.37 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 20.25 Bn
10 Alx Oncology Holdings 186.59 Mn 186.59 Mn - 136.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 136.19 Mn
Mar 31, 2026 151.35 Mn
Dec 31, 2025 25.98 Mn
Sep 30, 2025 44.80 Mn
Jun 30, 2025 64.42 Mn
Mar 31, 2025 88.30 Mn
Dec 31, 2024 113.62 Mn
Sep 30, 2024 136.81 Mn
Jun 30, 2024 159.32 Mn
Mar 31, 2024 164.20 Mn
Dec 31, 2023 189.71 Mn
Sep 30, 2023 168.75 Mn
Jun 30, 2023 212.69 Mn
Mar 31, 2023 240.39 Mn
Dec 31, 2022 263.46 Mn
Sep 30, 2022 286.96 Mn
Jun 30, 2022 316.32 Mn
Mar 31, 2022 343.60 Mn
Dec 31, 2021 363.05 Mn
Sep 30, 2021 385.17 Mn
API Access

Alx Oncology Holdings Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=ALXO&period=max&api_key=YOUR_API_KEY